Apresentação Pessoal

RESUMO CURRICULAR

1, Personal Data

Name: Jorge Manuel Silva Junqueira Polónia

Name under which publishes, J Polonia or JJ Polonia or Jorge Polonia

Identity card number: 2860115

Tax identification number:147846285

 Date of birth: 08-01-1953 Place of birth: Porto

 Nationality: Portuguese Sex: M

ORCID ID orcid.org/0000-0002-0133-7217

 

2. Institutional addresses:

Department of Medicine, Faculty of Medicine or Porto, Portugal

Alameda Prof. Hernâni Monteiro, 4200-319 Porto

Phone : +351 22 551 3600

Email . jpolonia@med.up.pt

or

Porto Pharmacovigilance Unit

CINTESIS

Alameda Prof. Hernâni Monteiro, 4200-319 Porto

Phone : +351 22 551 3600

Email . jpolonia@med.up.pt

ORCID iD: 0000-0002-0133-7217 

3. Situação Profissional Atual, Present Professional Situation

- Professor Catedratico de Medicina Interna, Departamento de Medicina da Faculdade Medicina do Porto; Full Professor of Internal Medicine, Department of Medicine of Faculty of Medicine of Porto (Jubilado em Janeiro 2023)

- Coordenador da Unidade de Farmacovigilancia do Norte do Infarmed - na Faculdade de Medicina do Porto; Director of Porto Pharmacovigilance Unit of Infarmed, in Faculty of Medicine of Porto

- Consultor Senior of Hypertension/Internal Mediicne da Unidade de Hipertensão & Risco Cardiovascular do Hospital Pedro Hispano, Matosinhos, Senior Consultant of Hypertension/Internal Mediicne in Blood Pressure and Cardiovascular Risk Unit of Hospital Pedro Hispano, Matosinhos

 - Membro do Council of the European Society of Hypertension (2017-presente)

- Investigador (Researcher) do CINTESIS Centro de Investigação em Tecnologias e Serviços de Saúde- Faculdade Medicina Universidade do Porto 

  

     4¸Formação Académica e Hospitalar, Academic & Hospitalar Formation;


ESPECIALIDADES MÉDICAS:

ESPECIALISTA EM MEDICINA INTERNA
ESPECIALISTA EM FARMACOLOGIA CLÍNICA
ESPECIALISTA EUROPEU DE HIPERTENSÃO CLÍNICA (ESH)

Carreira Academica

1975 - Monitor de Terapêutica da Faculdade Medicina do Porto (FMUP)

1976- Licenciatura Medicina na Faculdade Medicina do Porto – 17/20 valores

1977-1980 - Internato Geral, Serviço Medico à Periferia e Serviço Militar Obrigatorio

1983-1989 - Assistente convidado de Terapêutica 40%, FMUP  

1986-1987 - Research Fellow  Glasgow Western Infirmary, UK   Blood Pressure Unit 18 months 

1987 - Especialista em Farmacologia Clinica da Ordem dos Medicos

1987 - Terminou o Internato de Medicina Interna no HSJ com a classificção de 19.8 valores

1989 - Doutoramento em Medicina – Farmacologia Clinica - FMUP  - Distinção e Louvor unanimidade, Very Good by unanimous decision and cum suma laude

1990-1998 Professor Auxiliar Convidado de Terapeutica 40% FMUP

1993 . Agregação em Medicina – Aprovado por Unanimidade (Juri de 41 Porofessores) FMUP

1998 – Professor Associado de Farmacologia Clinica a FMUP (concurso – 1º lugar) a 100%

1993-1998 - Responsável pela Unidade de Farmacologia Clinica da FMUP

1998- 2013  Professor Associado c/ Agregação de Farmacologia Clinica a FMUP (concurso – 1º lugar) a 100%

2001 - Especialista Hipertensão Clinica pela European Society Hypertension

2005 -  presente . Prof. Catedratico Convidado 0% SA Ciencias Saude Universidade de Aveiro

2013 – 2020 - Professor Associado c/ Agregação do Departamento Medicina FMUP 100%

2019 – presente – Co-regencia disciplina Pratica Clinica, FMUP

2020-2021 - Regencia da Disciplina Propedeutica Medica II da FMUP

2021-presente - Professor Catedrático de Medicina Interna do Departamento de Mediicina da Faculdade Medicina do Porto

 

Carreira Hospitalar e pós graduações

1977-1980 - Internato Geral, Serviço Medico à Periferia e Serviço Militar Obrigatorio

1977- Curso de Hidrologia e Climatologia FMUP – 16/20  valores

1981- 1986 Internato Hospitalar Medicina Interna no Hospital S Joao

1981- 1986 – Frequência do Internato Cardiologia do Hospital S Joao

1986-1987 - Research Fellow  Glasgow Western Infirmary, UK   Blood Pressure Unit 18 months 

1987- Exame da Especialidade de Medicina Interna – 19,8/20  valores  

1988-1994 - Assistente Hospitalar Medicina Interna Hospital S. Joao

1994- Grau Consultor em Medicina Interna (Ass Hospital Graduado) H S Joao

1994-1998- Consultor em Medicina Interna (Ass Hospital Graduado) H S Joao

1998-presente Consultor Sénior Unidade Hipertensão Risco CV – Hospital Pedro Hispano

2001 – Titulo de Especialista Hipertensão Clinica pela European Society Hypertension

Outros Cargos Profissionais

1995- 1999 - Vogal da Comissao Nacional de Farmacovigilância do Infarmed

1998-1999  - Presidente da Associação Portuguesa Hipertensao da Soc Port Cardiologia

1998 - pres  Vogal da Comissao de Farmacia e Terapeutica da SRN Ordem dos Medicos

1998 - pres  Membro correspondente da Academia Portuguesa de Medicina

1999-2000 – Presidente da Associação Portuguesa de Hipertensão da Sociedade Portuguesa de Cardiologia

2000-pres Coordenador da Unidade de Farmacovilancia do Norte Infarmed (FMUP)

2002-2003 Presidente Colegio de Farmacologia Clinica da Ordem dos Medicos

2003 e 2011 - Vogal Comissao Redação das Normas de “Hipertensao” da DGS

2013 e 2018  -Participação nos painéis de avaliação das ESH/ESC Guidelines Hipertensão

2017-pres -  Membro do Board da European Society Hypertension

 

  

5. Scientific Activity

Domains – Internal Medicine, Hypertension and Metabolic disorders, Clinical Pharmacology, Pharmacovigilance

Activity	number
Coordenador - Investigador principal de projectos nacionais e internacionais Coordenator of National and International Projects	19
Trabalhos publicados em extenso em revistas indexadas a PubMed; Fullpapers – in peer review journals indexed to Pubmed	152
Trabalhos publicados em resumo em revistas indexadas a PubMed; Abstracts published – in peer review journals indexed to Pubmed	228
Livros e Capitulos de Livros Cientificos; Books and Books Chapiters	52
Conferências / moderação em Congressos Internacionais por convite; Lectures, moderation in International Congress by invitation	83
Orientação de doutoramentos (concluídos); Supervision of concluded PhDs;	10
Orientação de Mestrados (concluídos); Supervision of concluded Masters	16
Prémios Cientificos recebidos; Scientific Awards received	25
Referee of 13 Scientific Journals and member of Editorial Board of 4  (2 internacionals) e Membro de 8 Scientific Societies	13

 
Dos 25 Premios recebidos destacam-ae

2022 - Menção Honrosa . Premio Bial 2022. Fundação Bial
2020 – Premio Anadial da Sociedade  Portuguesa da Nefrologia
2016  -Best Poster Presentation Award Silver. 26th Scientific Meeting on The International Society of Hypertension, Seoul 
2014 - Premio BIAL 2014 de Medicina Clinica, Fundação Bial.
2014 - ALBERTO FERRARI AWARD. European and International Societies of Hypertension, Athens,
2014-  Premio Fernando de Padua de Hipertensao da Soiciedade Portuguesa de Hipertensao
2008.- Mensao Honrosa. Premio Bial 2008. Fundação Bial
2006 -  Premio Astra Zeneca de Investigação da Sociedade Potuguesa Cardiologia
2005 - Premio Delta de Hipertensao da Sociedade Potuguesa Cardiologia
1999 - Premio Hoerst da Sociedade Potuguesa Cardiologia
1999 - Premio “Nunes Correa Verdades de Faria “Avanços na Investigação das doenças do coração”  Santa Casa da Misericórdia de Lisboa
1997 - Premio Luso-Farmaco da Sociedade Potuguesa Cardiologia
1990 e 1994 . 2ºs Prémios Pfizer de Investigação Sociedade de Ciências Médicas de Lisboa
1988 e 1991 - 1ºs Premios Squibb de Hipertensao da Sociedade Potuguesa Cardiologia

6. Actividade docente, Teaching Activity

Pregraduação

- Disciplina Terapeutica e Farmacologia Clinica da FMUP – Responsavel pelas as aulas teóricas e seminários nos temas de Farmacovigilancia, Farmacologia Clinica dos antihipertensores, anti-diabéticos e medicamentos na insuficiência cardíaca (1988–2016)

- Regencia Disciplina de Fisiopatologia e Farmacoterapia na  Faculdade de Farmacia da UP (1993-1996)

- Regencia da Disciplina Terapeutica na Faculdade Medicina Dentaria da UP (1993-2000)

- Disciplina opcional de Terapêutica Cardiovascular – Responsabilidade por 2 Seminarios “Guidelines da Hipertensão Arterial recentes. (2016-2020)

- Unidade Curricular de Doenças Cardiovasculares da FMUP  e no ensino prático semanal do diagnóstico e terapêutica da Hipertensão Arterial e Risco Cardiovascular (2016-presente)

- Regencia da Disciplina Propedeutica Medica II da FMUP (2020-2021)

- Disciplina da Pratica Clinica da FMUP – Co-regencia (2019- presente)

Pos-Graduação

Cursos de pós graduação de Educação Contínua da FMUP:

Responsavel por “Curso básico de Monitorização Ambulatória da Pressão Arterial de 24 horas e Velocidade da Onda de Pulso Carotídeo femoral” (2018-presente)

Responsavel por “Curso de Actualização em Farmacovigilância”. (2015-presente)  

Colaboração com Cursos de “Especialização em Geriatria Clínica”, de “Especialização em Medicina Desportiva” e de “Nutrição Clínica na Medicina Geral e Família”

Colaboração Mestrados e Programas Doutorais. Mestrado de Nutrição Clínica da FCNUP e Programas doutorais na FMUP: “Programa de Doutoramento em Ciências Cardiovasculares”, “Programa de doutoramento em Farmacologia e Toxicologia Experimentais e Clinicas” e “Programa de doutoramento Investigação Clínica e em Serviços de Saúde”.

7 – Organização de Eventos Cientificos , Organization of Scientific Events.

- Member of the Scientific Committee of the Annual Meeting of the Portuguese Society of Hypertension (2005-2021)

- Organiser of 22 Annual Scientific Meeting of Hypertension and cardiovascular risk – of Matosinhos (1998-2021)


8.. Responsabilidade de Investigação Clinica

# Investigador Principal Nacional de 4 Estudos Multicentricos Internacionais (Estudos ALTITUDE, RALES, ONTARGET, REASON)

 # Investigador Principal de  5 Estudos Multicentricos Nacionais

 # Investigador Principal de 21 Estudos epidemiologicos Nacionais

(Publicações anexas numeros 9, 12, 16, 17, 19, 20, 24, 25, 27, 30, 31, 35, 37, 39, 40, 41, 46, 47, 48, 51, 54)

9. Outras actividades Cientificas

Membro das Comissões Organizadoras de Varias Jornadas e Congressos Nacionais e Internacionais na Areas da Hipertensao, Diabetes e Risco cardiovascular.

 -Membro  Organizador de  22 Jornadas de Hipertensao e Risco Cardiovascular de Matosinhos (1999-2021)

10. Publicação Cientifica

Publicações em extenso em revistas indexadas com peer review 2022-2023
       1. Aerobic exercise improves central blood pressure and blood pressure variability among patients with resistant hypertension: results          of the EnRicH trial. Lopes S, Mesquita-Bastos J, Garcia C, Leitão C, Ribau V, Teixeira M, Bertoquini S, Ribeiro IP, de Melo JB, Oliveira            J, Figueiredo D, Guimarães GV, Pescatello LS, Polonia J, Alves AJ, Ribeiro F.Hypertens Res. 2023 Feb 22. doi: 10.1038/s41440-023-            01229-7.
       2. Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research.            Ferreira da Silva R, Silva AM, Morato M, Ribeiro-Vaz I, Polónia JJ.J Clin Pharmacol. 2023 May;63(5):521-525.  

3. Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey. Ferreira-da-Silva R, Alves JM, Vieira C, Silva AM, Marques J, Morato M, Polónia JJ, Ribeiro-Vaz I.J Community Health. 2023 Apr;48(2):295-30
4. Could salt intake directly affect the cerebral microvasculature in hypertension? Monteiro A, Castro P, Pereira G, Ferreira C, Duque C, Sorond F, Milstead A, Higgins JP, Polónia J, Azevedo E.J Stroke Cerebrovasc Dis. 2022 Sep;31(9):106632.
5. Comparison of Blood Pressure Variability between 24 h Ambulatory Monitoring and Office Blood Pressure in Diabetics and Nondiabetic Patients: A Cross-Sectional Study. Rouxinol-Dias AL, Gonçalves ML, Ramalho D, Silva J, Barbosa L, Polónia J.Int J Hypertens. 2022 Jun 21;2022:1022044
6. The blood pressure response to acute exercise predicts the ambulatory blood pressure response to exercise training in patients with resistant hypertension: results from the EnRicH trial. Lopes S, Mesquita-Bastos J, Garcia C, Figueiredo D, Oliveira J, Guimarães GV, Pescatello LS, Polonia J, Alves AJ, Ribeiro F.Hypertens Res. 2022 Aug;45(8):1392-1397
7. [Pharmacovigilance of COVID-19 Vaccines in Pregnant and Lactating Women]. Silva AM, Ribeiro-Vaz I, Ferreira-da-Silva R, Cruz-Correia R, Polónia J, Bernardes J.Acta Med Port. 2021 Dec 2;34(12):807-809.

Publicações em extenso em revistas indexadas com peer review 2011-2021 (10 anos)

1. Lopes S, Mesquita-Bastos J, Garcia C, Leitao C, Bertoquini S, Ribau V, Polonia J, et al. Physical Activity is Associated With Lower Arterial Stiffness in Patients With Resistant Hypertension. Heart Lung Circ. 2021;30(11):1762-8.
2. Lopes S, Mesquita-Bastos J, Garcia C, Figueiredo D, Carvalho P, Oliveira J, Polonia J,et al. Are subjective measures the answer to assess physical inactivity on a daily basis in patients with resistant hypertension? J Hum Hypertens. 2021.
3. Lopes S, Mesquita-Bastos J, Garcia C, Bertoquini S, Ribau V, Teixeira M, Polonia J,et al. Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension: A Randomized Clinical Trial. JAMA Cardiol. 2021.
4. Lopes S, Afreixo V, Teixeira M, Garcia C, Leitao C, Gouveia M, Polonia J,et al. Exercise training reduces arterial stiffness in adults with hypertension: a systematic review and meta-analysis. J Hypertens. 2021;39(2):214-22.
5. Kreutz R, Dobrowolski P, Prejbisz A, Algharably EAE, Bilo G, Creutzig F, Polonia J,et al. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021;39(6):1077-89.
6. Ferreira-da-Silva R, Ribeiro-Vaz I, Silva AM, Marques J, Polonia JJ. [Looking back on 20 years of work at the Porto Pharmacovigilance Centre, Portugal]. Cad Saude Publica. 2021;37(10):e00304420.
7. Ferreira-da-Silva R, Ribeiro-Vaz I, Morato M, Polonia JJ. Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era. Int J Clin Pharm. 2021;43(4):1133-8.
8. Pereira da Silva A, Costa MDC, Aguiar L, Matos A, Gil A, Gorjao-Clara J, Polonia J, et al. Impact on Longevity of Genetic Cardiovascular Risk and Lifestyle including Red Meat Consumption. Oxid Med Cell Longev. 2020;2020:1305413.
9. Faria J, Mesquita Bastos J, Bertoquini S, Silva J, Polonia J. Long-Term Risk of Progression to Sustained Hypertension in White-Coat Hypertension with Normal Night-Time Blood Pressure Values. Int J Hypertens. 2020;2020:8817544.
10. Borghi C, Tsioufis K, Agabiti-Rosei E, Burnier M, Cicero AFG, Clement D, Polonia J, et al. Nutraceuticals and blood pressure control: a European Society of Hypertension position document. J Hypertens. 2020.
11. Polonia J, Rocha-Gonçalves F. A evoluc ̧ão histórica do envolvimento dos sistemas neuro-humorais no conhecimento da fisiopatologia e do tratamento da insuficiência cardíaca. Rev Port Cardiol. 2019:in press.
12. Polonia J, Baptista C, Silva J, Barbosa L. Unattended versus two attended, ambulatory and central blood pressure measurements in hypertensive patients with and without diabetes. Blood Press. 2019:1-8.
13. Monteiro P, Aguiar C, Matos P, Silva-Nunes J, Birne R, Branco P, Polonia J, et al. Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease. Rev Port Cardiol. 2019;38(10):721-35.
14. Izquierdo MC, Lopes S, Teixeira M, Polonia J, Alves AJ, Mesquita-Bastos J, Polonia J, et al. The Chester step test is a valid tool to assess cardiorespiratory fitness in adults with hypertension: reducing the gap between clinical practice and fitness assessments. Hypertens Res. 2019;42(12):2021-4.
15. Ferro A, Teixeira D, Pestana D, Monteiro R, Santos CC, Domingues VF, Polonia J, et al. POPs' effect on cardiometabolic and inflammatory profile in a sample of women with obesity and hypertension. Arch Environ Occup Health. 2019;74(6):310-21.
16. Faria J, Mesquita-Bastos J, Bertoquini S, Silva J, Barbosa L, Polonia J. Long-term cardiovascular risk of white-coat hypertension with normal night-time blood pressure values. Blood Press Monit. 2019;24(2):59-66.
17. Cotter J, Cotter MJ, Oliveira P, Cunha P, Torres E, Polonia J. Comparison of Salt Intake in Children to that of their Parents. Nephron. 2019;142(4):284-90.
18. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Polonia J, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041.
19. Tavares L, Calhau C, Polonia J. Assessment of cardiovascular risk and social framework of Cape Verdean university students studying in Portugal. Rev Port Cardiol. 2018;37(7):577-82.
20. Rouxinol-Dias A, Araujo S, Silva JA, Barbosa L, Polonia J. Association between ambulatory blood pressure values and central aortic pressure in a large population of normotensive and hypertensive patients. Blood Press Monit. 2018;23(1):24-32.
21. Rodrigues PP, Ferreira-Santos D, Silva A, Polonia J, Ribeiro-Vaz I. Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network. Artif Intell Med. 2018;91:12-22.
22. Jessen N, Damasceno A, Silva-Matos C, Tuzine E, Madede T, Mahoque R, Polonia J, et al. Hypertension in Mozambique: trends between 2005 and 2015. J Hypertens. 2018;36(4):779-84.
23. Costa MJ, Herdeiro MT, Polonia JJ, Ribeiro-Vaz I, Botelho C, Castro E, et al. Type B adverse drug reactions reported by an immunoallergology department. Pharm Pract (Granada). 2018;16(1):1070.
24. Araujo S, Rouxinol-Dias A, Mesquita-Bastos J, Silva J, Barbosa L, Polonia J. Ambulatory blood pressure monitoring profiles in a cross-sectional analysis of a large database of normotensive and true or suspected hypertensive patients. Rev Port Cardiol. 2018;37(4):319-27.
25. Polonia J, Lobo MF, Martins L, Pinto F, Nazare J. Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population. J Hypertens. 2017;35(3):477-86.
26. Polonia J, Lobo M, Martins L, Pinto F, Nazare J. Reply. J Hypertens. 2017;35(5):1120-2.
27. Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S. Annual deterioration of renal function in hypertensive patients with and without diabetes. Vasc Health Risk Manag. 2017;13:231-7.
28. Polonia J. Neutrophil-to-lymphocyte ratio and ambulatory blood pressure: Exploring the link between inflammation and hypertension. Rev Port Cardiol. 2017;36(2):107-9.
29. Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, Polonia J, et al. Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. Hypertension. 2016;67(4):693-700.
30. Polonia J, Monteiro J, Almeida J, Silva JA, Bertoquini S. High salt intake is associated with a higher risk of cardiovascular events: a 7.2-year evaluation of a cohort of hypertensive patients. Blood Press Monit. 2016;21(5):301-6.
31. Polonia J, Carvalho D, Nazare J, Martins L, da Silva PM, Aguiar C, et al. Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal. J Hum Hypertens. 2016;30(11):726-30.
32. Polonia J. Preeclampsia: a fascinating syndrome due not only to oxidative stress. Rev Port Cardiol. 2016;35(9):477-8.
33. Mendes Marques JI, Polonia JM, Figueiras AG, Costa Santos CM, Herdeiro MT. Nurses' attitudes and spontaneous adverse drug reaction reporting: a case-control study in Portugal. Journal of nursing management. 2016;24(3):409-16.
34. Huang L, Crino M, Wu JH, Woodward M, Land MA, McLean R, Polonia J, et al. Reliable Quantification of the Potential for Equations Based on Spot Urine Samples to Estimate Population Salt Intake: Protocol for a Systematic Review and Meta-Analysis. JMIR Res Protoc. 2016;5(3):e190.
35. Almeida J, Monteiro J, Silva JA, Bertoquini S, Polonia J. Central pressures and central hemodynamic values in white coat hypertensives are closer to those of normotensives than to those of controlled hypertensives for similar age, gender, and 24-h and nocturnal blood pressures. Rev Port Cardiol. 2016;35(11):559-67.
36. Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, .. Polonia J, et al. Prognostic impact of sex-ambulatory blood pressure interactions in 10 cohorts of 17 312 patients diagnosed with hypertension: systematic review and meta-analysis. J Hypertens. 2015;33(2):212-20.
37. Monte M, Cambao M, Mesquita Bastos J, Polonia J. Reproducibility of ambulatory blood pressure values and circadian blood pressure patterns in untreated subjects in a 1-11 month interval. Rev Port Cardiol. 2015;34(11):643-50.
38. Marques da Silva P, Carvalho D, Nazare J, Martins L, Aguiar C, Manso MC, et al. Prevalence of microalbuminuria in hypertensive patients with or without type 2 diabetes in a Portuguese primary care setting: The RACE (micRoAlbumin sCreening survEy) study. Rev Port Cardiol. 2015;34(4):237-46.
39. Polonia J, Olival C, Ribeiro S, Silva JA, Barbosa L. [Assessment of central hemodynamic properties of the arterial wall in women with previous preeclampsia]. Rev Port Cardiol. 2014;33(6):345-51.
40. Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. J Hypertens. 2014;32(6):1211-21.
41. Polonia J, Madede T, Silva JA, Mesquita-Bastos J, Damasceno A. Ambulatory blood pressure monitoring profile in urban African black and European white untreated hypertensive patients matched for age and sex. Blood Press Monit. 2014;19(4):192-8.
42. Pereira T, Maldonado J, Polonia J, Silva JA, Morais J, Rodrigues T, et al. Aortic pulse wave velocity and HeartSCORE: improving cardiovascular risk stratification. a sub-analysis of the EDIVA (Estudo de DIstensibilidade VAscular) project. Blood Press. 2014;23(2):109-15.
43. Marques J, Ribeiro-Vaz I, Pereira AC, Polonia J. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Int J Pharm Pract. 2014;22(4):275-82.
44. Investigators A-H, Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, et al. Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension. J Hypertens. 2014;32(12):2332-40; discussion 40.
45. Duarte-Silva D, Figueiras A, Herdeiro MT, Teixeira Rodrigues A, Silva Branco F, Polonia J, et al. PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs. Pharm Pract (Granada). 2014;12(2):396.
46. Ribeiro-Vaz I, Marques J, Demoly P, Polonia J, Gomes ER. Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority. Eur J Clin Pharmacol. 2013;69(3):673-81.
47. Polonia JJ, Magalhaes MT, Senra D, Barbosa L, Silva JA, Ribeiro SM. Association of 24-h urinary salt excretion with central haemodynamics and assessment of food categories contributing to salt consumption in Portuguese patients with hypertension. Blood Press Monit. 2013;18(6):303-10.
48. Pessanha P, Viana M, Ferreira P, Bertoquini S, Polonia J. Diagnostic value and cost-benefit analysis of 24 hours ambulatory blood pressure monitoring in primary care in Portugal. BMC cardiovascular disorders. 2013;13:57.
49. Marques JI, Ribeiro Vaz I, Santos C, Polonia J. Adverse events with the influenza A(H1N1) vaccine Pandemrix(R) at healthcare professionals in Portugal. Acta Med Port. 2013;26(2):107-12.
50. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219.
51. Cotter J, Cotter MJ, Oliveira P, Cunha P, Polonia J. Salt intake in children 10-12 years old and its modification by active working practices in a school garden. J Hypertens. 2013;31(10):1966-71.
52. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. The New England journal of medicine. 2012;367(23):2204-13.
53. Herdeiro MT, Ribeiro-Vaz I, Ferreira M, Polonia J, Falcao A, Figueiras A. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug Saf. 2012;35(8):655-65.
54. Herdeiro MT, Ferreira M, Ribeiro-Vaz I, Polonia J, Pereira AC. The Portuguese Pharmacovigilance System Acta Med Port 2012;25(4):241-9.
55. Ribeiro-Vaz I, Herdeiro MT, Polonia J, Figueiras A. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica. 2011;45(1):129-35.
56. Pereira T, Maldonado J, Polonia J, Alberto Silva J, Morais J, Marques M. A statistical definition of aortic pulse wave velocity normality in a Portuguese population: a subanalysis of the EDIVA project. Rev Port Cardiol. 2011;30(9):691-8.
57. Maldonado J, Pereira T, Polonia J, Silva JA, Morais J, Marques M. Arterial stiffness predicts cardiovascular outcome in a low-to-moderate cardiovascular risk population: the EDIVA (Estudo de DIstensibilidade VAscular) project. J Hypertens. 2011;29(4):669-75.

 

11. INDICE H (2019) 
221 publicações analisadas - Google schollar (2023)
h-indice 42 
Indice i10 113
Numero citações 39775